Hepatitis B Awareness and Knowledge in Asian Communities in British Columbia.

Authors:
Yau AH; Ford JA; Kwan PW; Chan J; Choo Q and 4 more

Journal:
Can J Gastroenterol Hepatol

Publication Year: 2016

DOI:
10.1155/2016/4278724

PMCID:
PMC4904637

PMID:
27446839

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Can J Gastroenterol Hepatol

Abbreviation: Can J Gastroenterol Hepatol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Hepatitis C Attributable Healthcare Costs and Mortality among Immigrants: A Population-Based Matche…
Erman A; Sahakyan Y; Everett K and 6 more (2024) - Transparency Score: 3/6
Prevalence of Esophageal Eosinophilia, Eosinophilic Esophagitis, and Lymphocytic Gastritis in Child…
Alaifan MA; Khayat A; Bokhary RY and 4 more (2024) - Transparency Score: 2/6
Construction and Analysis of Hepatocellular Carcinoma Prognostic Model Based on Random Forest.
Wang Y; Ma L; Xue P and 6 more (2023) - Transparency Score: 3/6
Diabetes and Metabolic Disorders: Their Impact on Cardiovascular Events in Liver Transplant Patient…
Di Cola S; Cusi G; Lapenna L and 6 more (2023) - Transparency Score: 2/6
Disparate Intent-to-Treat Outcomes for Pediatric Liver Transplantation Based on Indication.
Lang A; Goff C; Montgomery A and 4 more (2023) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing Interests Dr. Eric Yoshida is an investigator of clinical trials sponsored by Gilead Sciences, AbbVie, Janssen, Merck, and Boehringer Ingelheim. He has received honoraria for CME lectures sponsored by Gilead Sciences Canada and Merck Canada. He has provided Ad Board lectures for AbbVie Canada, Boehringer Ingelheim, and Celgene Canada. He has been a member of a compassionate release advisory committee sponsored by Gilead Sciences."

Evidence found in paper:

"Competing Interests: Dr. Eric Yoshida is an investigator of clinical trials sponsored by Gilead Sciences, AbbVie, Janssen, Merck, and Boehringer Ingelheim. He has received honoraria for CME lectures sponsored by Gilead Sciences Canada and Merck Canada. He has provided Ad Board lectures for AbbVie Canada, Boehringer Ingelheim, and Celgene Canada. He has been a member of a compassionate release advisory committee sponsored by Gilead Sciences."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025